$346 Million is the total value of Parkman Healthcare Partners LLC's 69 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | New | MERCK & CO INC | $20,009,000 | – | 220,000 | +100.0% | 5.78% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $16,707,000 | – | 155,425 | +100.0% | 4.82% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $14,220,000 | – | 95,000 | +100.0% | 4.10% | – |
| SGEN | New | SEATTLE GENETICS INC | $13,736,000 | – | 120,221 | +100.0% | 3.96% | – |
| KOD | New | KODIAK SCIENCES INC | $12,558,000 | – | 174,538 | +100.0% | 3.62% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $12,436,000 | – | 275,000 | +100.0% | 3.59% | – |
| EIDX | New | EIDOS THERAPEUTICS INC | $11,895,000 | – | 207,271 | +100.0% | 3.43% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $9,933,000 | – | 95,000 | +100.0% | 2.87% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $9,891,000 | – | 45,176 | +100.0% | 2.86% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $9,623,000 | – | 265,840 | +100.0% | 2.78% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $9,585,000 | – | 500,000 | +100.0% | 2.77% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $9,163,000 | – | 15,500 | +100.0% | 2.64% | – |
| VCEL | New | VERICEL CORP | $8,326,000 | – | 478,500 | +100.0% | 2.40% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $8,045,000 | – | 134,959 | +100.0% | 2.32% | – |
| SILK | New | SILK ROAD MEDICAL INC | $7,874,000 | – | 195,000 | +100.0% | 2.27% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $7,709,000 | – | 588,059 | +100.0% | 2.22% | – |
| DXCM | New | DEXCOM INC | $7,656,000 | – | 35,000 | +100.0% | 2.21% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $7,350,000 | – | 25,000 | +100.0% | 2.12% | – |
| XBI | New | SPDR SERIES TRUSTput | $7,133,000 | – | 75,000 | +100.0% | 2.06% | – |
| TFX | New | TELEFLEX INC | $7,002,000 | – | 18,600 | +100.0% | 2.02% | – |
| HAE | New | HAEMONETICS CORP | $6,923,000 | – | 60,250 | +100.0% | 2.00% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $6,579,000 | – | 275,505 | +100.0% | 1.90% | – |
| IQV | New | IQVIA HLDGS INC | $6,374,000 | – | 41,250 | +100.0% | 1.84% | – |
| TPTX | New | TURNING POINT THERAPEUTICS I | $6,318,000 | – | 101,434 | +100.0% | 1.82% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $5,287,000 | – | 240,000 | +100.0% | 1.53% | – |
| NTRA | New | NATERA INC | $5,082,000 | – | 150,843 | +100.0% | 1.47% | – |
| MTEM | New | MOLECULAR TEMPLATES INC | $4,779,000 | – | 341,695 | +100.0% | 1.38% | – |
| ICAD | New | ICAD INC | $4,667,000 | – | 600,686 | +100.0% | 1.35% | – |
| AXNX | New | AXONICS MODULATION TECH INC | $4,606,000 | – | 166,231 | +100.0% | 1.33% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $4,031,000 | – | 35,000 | +100.0% | 1.16% | – |
| MSON | New | MISONIX INC | $3,955,000 | – | 212,500 | +100.0% | 1.14% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $3,937,000 | – | 1,141,212 | +100.0% | 1.14% | – |
| RGNX | New | REGENXBIO INC | $3,482,000 | – | 85,000 | +100.0% | 1.00% | – |
| KRMD | New | REPRO MED SYS INC | $3,452,000 | – | 528,572 | +100.0% | 1.00% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $3,271,000 | – | 16,000 | +100.0% | 0.94% | – |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $3,200,000 | – | 23,004 | +100.0% | 0.92% | – |
| ATEC | New | ALPHATEC HOLDINGS INC | $3,193,000 | – | 450,000 | +100.0% | 0.92% | – |
| XENT | New | INTERSECT ENT INC | $3,125,000 | – | 125,500 | +100.0% | 0.90% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $3,104,000 | – | 932,141 | +100.0% | 0.90% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $2,925,000 | – | 165,000 | +100.0% | 0.84% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $2,909,000 | – | 135,676 | +100.0% | 0.84% | – |
| KIDS | New | ORTHOPEDIATRICS CORP | $2,819,000 | – | 60,000 | +100.0% | 0.81% | – |
| STXS | New | STEREOTAXIS INC | $2,813,000 | – | 531,718 | +100.0% | 0.81% | – |
| BLFS | New | BIOLIFE SOLUTIONS INC | $2,686,000 | – | 166,000 | +100.0% | 0.78% | – |
| RCM | New | R1 RCM INC | $2,670,000 | – | 205,720 | +100.0% | 0.77% | – |
| GH | New | GUARDANT HEALTH INC | $2,364,000 | – | 30,250 | +100.0% | 0.68% | – |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $2,250,000 | – | 621,511 | +100.0% | 0.65% | – |
| IRMD | New | IRADIMED CORP | $2,186,000 | – | 93,500 | +100.0% | 0.63% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $2,026,000 | – | 100,000 | +100.0% | 0.58% | – |
| GNMK | New | GENMARK DIAGNOSTICS INC | $2,020,000 | – | 420,000 | +100.0% | 0.58% | – |
| NEPH | New | NEPHROS INC | $1,987,000 | – | 199,724 | +100.0% | 0.57% | – |
| MNKD | New | MANNKIND CORP | $1,839,000 | – | 1,425,302 | +100.0% | 0.53% | – |
| INSP | New | INSPIRE MED SYS INC | $1,837,000 | – | 24,750 | +100.0% | 0.53% | – |
| AVRO | New | AVROBIO INC | $1,812,000 | – | 90,000 | +100.0% | 0.52% | – |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $1,648,000 | – | 82,294 | +100.0% | 0.48% | – |
| FTSV | New | FORTY SEVEN INC | $1,575,000 | – | 40,000 | +100.0% | 0.46% | – |
| MYOV | New | MYOVANT SCIENCES LTD | $1,543,000 | – | 99,413 | +100.0% | 0.44% | – |
| FLDM | New | FLUIDIGM CORP DEL | $1,392,000 | – | 400,000 | +100.0% | 0.40% | – |
| SPNE | New | SEASPINE HLDGS CORP | $1,350,000 | – | 112,440 | +100.0% | 0.39% | – |
| MBIO | New | MUSTANG BIO INC | $1,233,000 | – | 302,260 | +100.0% | 0.36% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,089,000 | – | 20,000 | +100.0% | 0.31% | – |
| CDMO | New | AVID BIOSERVICES INC | $1,078,000 | – | 140,523 | +100.0% | 0.31% | – |
| INFU | New | INFUSYSTEM HLDGS INC | $1,066,000 | – | 125,000 | +100.0% | 0.31% | – |
| XNCR | New | XENCOR INC | $860,000 | – | 25,000 | +100.0% | 0.25% | – |
| ITMR | New | ITAMAR MED LTDsponsored ads | $604,000 | – | 46,900 | +100.0% | 0.17% | – |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $557,000 | – | 91,091 | +100.0% | 0.16% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $425,000 | – | 225,000 | +100.0% | 0.12% | – |
| TELA | New | TELA BIO INC | $324,000 | – | 25,000 | +100.0% | 0.09% | – |
| APYX | New | APYX MED CORP | $299,000 | – | 35,395 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.